Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2013

Chapter 20 - Selection of clinical outcome measures in rehabilitation of people with movement disorders: theory and practice

from Section 5 - Measurement of therapy outcomes


1. JetteDU, HalbertJ, IversonC, MiceliE, ShahP. Use of standardized outcome measures in physical therapist practice: perceptions and applications. Phys Ther 2009;89:125–35.
2. World Health Organization. International Classification of Functioning, Disability and Health. Geneva: WHO, 2001
3. KeusS, HendriksH, BloemB, et al. Clinical practice guidelines for physical therapy in patients with Parkinson’s disease. Ned Tijdschr Fysiother 2004;114:1–92.
4. RaggiA, LeonardiM, AjovalasitD, et al. Functioning and disability in Parkinson’s disease. Disabil Rehabil 2010;32:S33–41.
5. GoetzCG, NuttJG, StebbinsGT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord 2008;23:2398–403.
6. YardleyL, BeyerN, HauerK, et al. Development and initial validation of the Falls Efficacy Scale-International (FES-I). Age Ageing 2005;34:614–19.
7. PackerTL, BoshoffK, DeJongeD. Development of the Activity Card Sort – Australia. Aust Occup Ther J 2008;55:199–206.
8. JohnsMW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1992;14: 540–5.
9. ButlandRJ, PangJ, GrossER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ (Clinical research ed) 1982;284(6329):1607–8.
10. BeckA, WardC, MendelsonM, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.
11. SchwabR, EnglandJ. Projection technique for evaluating surgery in Parkinson’s disease. In: GillinghamF, DonaldsonI, eds. Third Symposium in Parkinson’s Disease: Edinburgh: E & S Livingstone; 1969.
12. GiladiN, ShabtaiH, SimonES, et al. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000;6:165–70.
13. HoehnMM, YahrMD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42.
14. SchenkmanM, McFannK, BarónA. PROFILE PD: profile of function and impairment level experience with Parkinson disease – clinimetric properties of a rating scale for physical therapist practice. J Neurol Phys Ther 2010;34:182.
15. GoetzCG, TilleyBC, ShaftmanSR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129–70.
16. LawM, BaptisteS, McCollM, et al. The Canadian Occupational Performance Measure: an outcome measure for occupational therapy. Can J Occup Ther 1990;57:82–7.
17. PerryA, MorrisM, UnsworthC, et al. Therapy outcome measures for allied health practitioners in Australia: the AusTOMs. Int J Qual Health Care 2004;16:285–91.
18. SohS-E, McGinleyJ, MorrisME. Measuring quality of life in Parkinson’s disease: selection of an appropriate health-related quality of life instrument. Physiotherapy 2011;97:83–9.
19. de VetH, TerweeC, BouterL. Current challenges in clinimetrics. J Clin Epidemiol 2003;56:1137–41.
20. de VetH, TerweeC, MokkinkL, KnolD. Measurement in Medicine. Cambridge: Cambridge University Press, 2011.
21. de VetHC, TerweeCB, OsteloRW, et al. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 2006;4:54.
22. PodsiadloD, RichardsonS. The Timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatric Soc 1991;39:142–8.
23. MokkinkLB, TerweeCB, PatrickDL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737–45.
24. MorrisS, MorrisME, IansekR. Reliability of measurements obtained with the Timed “Up & Go” test in people with Parkinson disease. Phys Ther 2001;81–2.
25. SchragA, SpottkeA, QuinnNP, DodelR. Comparative responsiveness of Parkinson’s disease scales to change over time. Mov Disord 2009;24:813–18.
26. JenkinsonC, FitzpatrickR, PetoV, GreenhallR, HymanN. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 1997;26:353–5.
27. JaeschkeR, SingerJ, GuyattGH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15.
28. ShulmanLM, Gruber-BaldiniAL, AndersonKE, et al. The clinically important difference on the unified Parkinson’s disease rating scale. Arch Neurol 2010;67:64–70.
29. Huntington Study Group Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136–42.
30. GolbeL. A clinical rating scale and staging system for progressive supranuclear palsy. Neurology 1997;48:A326.
31. ComellaCL, LeurgansS, WuuJ, StebbinsGT, ChmuraT. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18:303–12.
32. BergK, Wood-DauphineeS, WilliamsJ. The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehabil Med 1995;27:27–36.
33. FranchignoniF, HorakFB, GodiM, NardoneA, GiordanoA. Using psychometric techniques to improve the Balance Evaluation Systems Test: the mini-BESTest. J Rehabil Med 2010;42:323–31.
34. WareJE Jr, SherbourneCD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473–83.
35. KruppL, LaRoccaN, Muir-NashJ, SteinbergA. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121–3.
36. KamperSJ, MaherCG, MackayG. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther 2009;17:163–70.
37. Turner-StokesL. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil 2009;23:362–70.